Chronic Graft Versus Host Disease (cGvHD)Symptoms, Doctors, Treatments, Advances & More
Learn About Chronic Graft Versus Host Disease (cGvHD)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Emory Winship Cancer Institute
Edmund Waller is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 41 years. Dr. Waller is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Transplant. Dr. Waller is board certified in American Board Of Internal Medicine, 1991.
Cleveland Clinic Main Campus
Betty Hamilton is a Transplant Surgeon practicing medicine in Cleveland, Ohio. She has been practicing medicine for over 26 years. Dr. Hamilton is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Febrile Neutropenia, Myeloproliferative Neoplasms (MPN), Bone Marrow Transplant, and Bone Graft. Dr. Hamilton is board certified in American Board Of Internal Medicine, 2013.
Moffitt Cancer Center, Magnolia Campus
Taiga Nishihori is an Internal Medicine provider practicing medicine in Tampa, Florida. Dr. Nishihori is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Graft. Dr. Nishihori is currently accepting new patients.
Background: * Chronic graft-versus-host disease (cGVHD) is a multi-organ alloimmune and autoimmune disorder that occurs following allogeneic hematopoietic stem cell transplantation (alloHSCT). It is characterized by immune dysregulation, immunodeficiency, impaired organ function, and decreased survival. * Each year about 8000 patients receive allogeneic hematopoietic stem cell transplant (alloHSCT) in North A...
Summary: This is a Phase 2 study to evaluate the efficacy, safety, and tolerability of axatilimab at 3 different dose levels in participants with recurrent or refractory active chronic graft versus host disease (cGVHD) who have received at least 2 prior lines of systemic therapy.